Open AccessCan spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?
Author(s) -
Flavio Cadegiani
Publication year - 2020
Publication title -
endocrinology and metabolism/american journal of physiology: endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 201
eISSN - 1522-1555
pISSN - 0193-1849
DOI - 10.1152/ajpendo.00136.2020
Subject(s) - spironolactone , medicine , ards , covid-19 , discontinuation , angiotensin receptor blockers , intensive care medicine , disease , renin–angiotensin system , heart failure , blood pressure , lung , infectious disease (medical specialty)